Matthew Gall - 27 Dec 2021 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role: Chief Financial Officer
Signature: /s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol: ITOS
Transactions as of: 27 Dec 2021
Net transactions value: -$232,250
Form type: 4
Filing time: 28 Dec 2021, 19:58:24 UTC
Previous filing: 12 Oct 2021
Next filing: 14 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITOS	Common Stock	Sale	$232,250	-5,000	-26%	$46.45	14,429	27 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.20 to $46.77, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.20 to $46.77, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.